Holen Sie sich die Stockscreener-App
1.42
2.38%
-0.05
Schlusskurs vom Vortag:
$1.47
Offen:
$1.46
24-Stunden-Volumen:
263.39K
Relative Volume:
0.11
Marktkapitalisierung:
$144.73M
Einnahmen:
$100.56M
Nettoeinkommen (Verlust:
$-119.05M
KGV:
-1.1545
EPS:
-1.23
Netto-Cashflow:
$-231.16M
1W Leistung:
-4.33%
1M Leistung:
-56.78%
6M Leistung:
+10.38%
1J Leistung:
-71.41%
1-Tages-Spanne:
$1.425
$1.50
1-Wochen-Bereich:
$1.40
$1.68
52-Wochen-Spanne:
$0.87
$6.14
Alector Inc Stock (ALEC) Company Profile
Firmenname
Alector Inc
Sektor
Branche
Telefon
415-231-5660
Adresse
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO
Vergleichen Sie ALEC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALEC
Alector Inc
|
1.43 | 148.78M | 100.56M | -119.05M | -231.16M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
420.67 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
632.59 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.00 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
815.91 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
181.01 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Alector Inc Stock (ALEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-22 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-10-22 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-10-22 | Herabstufung | Mizuho | Outperform → Neutral |
| 2025-10-22 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-10-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-07-28 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-12-17 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-12-16 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-11-29 | Bestätigt | H.C. Wainwright | Buy |
| 2024-11-26 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-12-14 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-12 | Eingeleitet | Deutsche Bank | Buy |
| 2023-09-25 | Eingeleitet | Goldman | Sell |
| 2023-09-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-09-09 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-13 | Eingeleitet | Goldman | Sell |
| 2022-03-08 | Herabstufung | Stifel | Buy → Hold |
| 2021-09-27 | Eingeleitet | William Blair | Outperform |
| 2021-01-15 | Fortgesetzt | BofA Securities | Buy |
| 2020-06-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-28 | Eingeleitet | Goldman | Buy |
| 2020-03-06 | Eingeleitet | Citigroup | Buy |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-02-19 | Eingeleitet | Stifel | Buy |
| 2019-11-21 | Eingeleitet | BTIG Research | Buy |
| 2019-03-04 | Eingeleitet | Barclays | Overweight |
| 2019-03-04 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-03-04 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Alector Inc Aktie (ALEC) Neueste Nachrichten
Why Alector Inc. stock remains undervaluedWeekly Earnings Recap & Low Drawdown Momentum Ideas - newser.com
Volatility clustering patterns for Alector Inc.2025 Market Overview & Breakout Confirmation Alerts - newser.com
Will Alector Inc. stock maintain dividend yieldPortfolio Return Summary & Safe Entry Zone Identification - newser.com
Is Alector Inc. (0Z2) stock resilient in recession scenariosSwing Trade & High Conviction Investment Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alector, Inc. (ALEC) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
How to track smart money flows in Alector Inc.Weekly Trade Review & Real-Time Stock Movement Alerts - newser.com
Why Alector Inc. (0Z2) stock attracts wealthy investorsQuarterly Portfolio Review & Advanced Swing Trade Entry Plans - newser.com
How Alector Inc. (0Z2) stock compares with market leadersPortfolio Value Report & AI Powered Market Trend Analysis - newser.com
Backtesting results for Alector Inc. trading strategies2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com
Is Alector Inc. (0Z2) stock supported by strong fundamentalsJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - newser.com
Why Alector Inc. stock attracts global investorsJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - newser.com
Alector, Inc. (ALEC) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Alector, Inc. (ALEC) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2025-10-31 | Alector, Inc. (ALEC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:ALEC | Press Release - Stockhouse
Will Alector Inc. stock attract ESG investors2025 Technical Overview & Accurate Entry and Exit Point Alerts - newser.com
Is Alector Inc. stock a defensive play in 2025Quarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Can Alector Inc. (0Z2) stock hold up in economic slowdown2025 Short Interest & Accurate Technical Buy Alerts - newser.com
Alector Announces Topline Results from Phase 3 INFRONT-3 Clinical Trial Evaluating Latozinemab - Insider Monkey
How to build a dashboard for Alector Inc. stock2025 Year in Review & Verified Stock Trade Ideas - newser.com
Evaluating Alector Inc. with trendline analysisJuly 2025 Trends & Verified Momentum Watchlists - newser.com
Is Alector Inc a good long term investmentTrend Following Strategies & High Return Trading Portfolio - earlytimes.in
Alector’s Latozinemab Study: A Promising Continuation for Neurodegenerative Disease Treatment - TipRanks
Bronstein, Gewirtz & Grossman, LLC Is Investigating Alector, Inc. (ALEC) And Encourages Investors to Connect - ACCESS Newswire
10 Best Stocks Under $3 to Invest In - Insider Monkey
Alector’s Phase 3 Trial of Latozinemab Fails to Meet Efficacy Endpoints in FTD-GRN Study - MyChesCo
Alector (ALEC) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Has Alector Inc. found a price floorPortfolio Risk Summary & Safe Entry Trade Signal Reports - newser.com
Alector (ALEC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Yahoo Finance
Alector (ALEC) Price Target Decreased by 42.61% to 2.24 - MSN
Is Alector Inc. stock attractive for ETFs2025 Earnings Impact & Advanced Swing Trade Entry Plans - fcp.pa.gov.br
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alector, Inc.ALEC - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alector, Inc.ALEC - PR Newswire
Finanzdaten der Alector Inc-Aktie (ALEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
0.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):